Sotera Health Company SHC 深 沪
已收盘 08-01 16:00:00 美东时间
11.15
-0.340
-2.96%
华盛通- 最 高11.41
- 今 开11.35
- 成交量 93.80万股
- 最 低 11.0201
- 昨 收 11.49
- 总市值 31.67亿
- 52周最高 17.08
- 市盈率 静 71.66
- 换手率 0.33%
- 52周最低 9.53
- 委 比 44.37%
- 总股本 2.84亿
- 历史最高 30.38
- 量 比 0.92
- 振 幅 3.39%
- 历史最低 5.78
- 每 手 1
- 风险率 1.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Preview: Bruker
Bruker (NASDAQ:BRKR) is gearing up to announce its quarterly earnings on Monday...
08-02 00:01
Shaftesbury Capital Announces Interim Dividend Impacting Exchangeable Bonds
Shaftesbury Capital ( ($GB:SHC) ) has shared an update. Shaftesbury Capital PLC...
07-30 23:47
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
Sotera Health Company announced the release of its second-quarter 2025 financial results on August 8, 2025, before market open, followed by a conference call at 9:00 a.m. EDT. Interested parties may join via phone or webcast.
07-28 11:38
Sotera Health Subsidiary Settles $34M Ethylene Oxide Claims
Sotera Health ( ($SHC) ) has provided an announcement. On July 23, 2025, Sterig...
07-24 19:55
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $13
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $15 to $13.
06-24 23:26
Goldman Sachs Upgrades Sotera Health to Buy, Raises Price Target to $17
Goldman Sachs analyst Matthew Sykes upgrades Sotera Health (NASDAQ:SHC) from Neutral to Buy and raises the price target from $14 to $17.
05-05 17:09
Earnings Scheduled For May 1, 2025
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repor...
05-01 16:32
美股大行评级 | 潜在涨幅77.95%！Devon Energy获Piper Sandler上调目标价至56美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1122473387096023041.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Devon Energy(DVN)"超配"评级，目标价从54美元升至56美元</p> <p>• Piper Sandler：维持Home Bancorp(HBCP)"超配"评级，目标价从60
04-25 10:28
美股大行评级 | 潜在涨幅38%！花旗：首予通用汽车(GM)"买入"评级，目标价62美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1122085978711785472.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Devon Energy(DVN)"超配"评级，目标价从54美元升至56美元</p> <p>• HC Wainwright & Co.：上调Dogwood Therapeutics(
04-24 09:56
